Calibr

Calibr was founded on the principle that the creation of new medicines can be accelerated by combining world-class biomedical research with state-of-the-art drug discovery and development capabilities. Leveraging the unique scientific framework of Scripps Research, Calibr has built a portfolio of drug candidates based on Scripps technologies and is shaping a new paradigm to advance nonprofit biomedical research to impact patients.